VKORC1-1639A allele influences warfarin maintenance dosage among Blacks receiving warfarin anticoagulation: a retrospective cohort study. (January 2018)

• Record Type: Journal Article
• Authors: Mili, Fatima Donia; Allen, Tenecia; Wadell, Paula Weinstein; Hooper, W Craig; Staercke, Christine De; Bean, Christopher J; Lally, Cathy; Austin, Harland; Wenger, Nanette K
• Is Part Of: Future cardiology. Volume 14:Number 1(2018)
• Page Start: 15
• Page End: 26
• Publication Date: 2018-01
• Subjects: anticoagulation -- Blacks -- CYP2C9 -- pharmacogenetics -- thromboembolism -- VKORC1 -- VKORC1-1639G>A warfarin; Cardiology -- Research -- Periodicals; 616.12005
• DOI: 10.2217/fca-2017-0025
• Languages: English
• ISSNs: 1479-6678

Abstract

Aim: The study objectives were to investigate the association between selected CYP2C9 and VKORC1 single nucleotide polymorphisms with serious bleeding or thrombotic risk, and to estimate mean daily maintenance dose of warfarin and international normalized ratio measurements among Blacks receiving warfarin anticoagulation.Methods: We conducted a retrospective cohort study among 230 Black adults receiving warfarin for a minimum of three consecutive months with a confirmed date of first dosage.Results: A lower mean daily maintenance dosage of warfarin was required to maintain an international normalized ratio measurement within the therapeutic range among Blacks with the VKORC1 -1639G>A variant alleles ([G/A vs G/G, p = 0.02], [A/A vs G/A, p = 0.008] and [A/A vs G/G, p = 0.001]).Conclusion: Data indicated that VKORC1 -1639A variant allele influenced warfarin daily maintenance dosage among our small, likely admixed Black patient population.